Screening for Predicted Beta-lactamases within Elizabethkingia anopheles
Abstract
Full Text:
PDFReferences
Eriksen, H.B., H. Gumpert, C.H. Faurholt, and H. Westh. 2017. Determination of Elizabethkingia diversity by MALDI-TOF mass spectrometry and whole-genome sequencing. Emerging Infectious Diseases 23:320-323.
Heesemann, J. 1993. Resistenzmechanismen gegen Betalaktamantibiotika. Infection 21: S4–S9.
Hsu, M.S., C.H. Liao, Y.T. Huang, C.Y. Liu, C.J. Yang, K.L. Kao, and P.-. Hsueh. 2011. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. European Journal of Clinical Microbiology & Infectious Diseases 30: 1271-1278.
Kämpfer, P., H. Matthews, S. P. Glaeser, K. Martin, N. Lodders, and I. Faye. 2012. Elizabethkingia anophelis sp. nov., isolated from the midgut of the mosquito Anopheles gambiae. International Journal Of Systematic And Evolutionary Microbiology 62: 1016-1016.
Kim, K.K., M.K. Kim, H.L. Ju, Y. P. Hye, and L. Sung-Taik. 2005. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. International Journal of Systematic and Evolutionary Microbiology 55: 1287-1293.
Lau, S. K.P., W.N. Chow, C.H. Foo, S.O.T. Curreem, G.C.S. Lo, J.L.L. Teng, J.H.K. Chen, R.H.Y. Ng, A.K.L. Wu, I.Y.Y. Cheung, S.K.Y. Chau, D.C. Lung, R.A. Lee, C.W.S. Tse, K.S.C. Fung, T.L. Que, and P.C.Y. Woo. 2016. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Scientific Reports 6: 26045.
Lin, Y.T., C.H. Chiu, Y.J. Chan, M.L. Lin, K.W. Yu, F.D. Wang, and C.Y. Liu. 2009. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scandinavian Journal of Infectious Diseases 41: 628-634.
Refbacks
- There are currently no refbacks.